FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brad Pohlman

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Disorders

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Nelli Bejanyan; Brian J Bolwell; Steven Andresen; R Dean; Hien Duong; Matt Kalaycio; Aleksandr Lazaryan; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; Shawnda Tench; Edward A Copelan
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Ronald Sobecks; M Yurch; Steven Andresen; Brian J Bolwell; R Dean; H Duong; Matt Kalaycio; Brad Pohlman; Lisa Rybicki; Edward A Copelan
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS.
J Waterman; Steven Andresen; Brian J Bolwell; Edward A Copelan; R Dean; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; John W Sweetenham; Matt Kalaycio
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brad Pohlman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Nelli Bejanyan; Brian J Bolwell; Steven Andresen; R Dean; Hien Duong; Matt Kalaycio; Aleksandr Lazaryan; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; Shawnda Tench; Edward A Copelan
Risk factors for 30-day hospital readmission following myeloablative allogeneic hematopoietic cell transplantation (allo-HCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):874-80.
2012: Ronald Sobecks; M Yurch; Steven Andresen; Brian J Bolwell; R Dean; H Duong; Matt Kalaycio; Brad Pohlman; Lisa Rybicki; Edward A Copelan
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS.
Bone marrow transplantation 2012;47(5):633-8.
2012: J Waterman; Steven Andresen; Brian J Bolwell; Edward A Copelan; R Dean; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; John W Sweetenham; Matt Kalaycio
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
Bone marrow transplantation 2012;47(4):488-93.
2011: S Malik; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; John W Sweetenham; S Tench; O Copelan; R Dean; H Duong; P Figueroa; Matt Kalaycio; AP Koo; Steven Andresen; Brian J Bolwell; Edward A Copelan
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation.
Bone marrow transplantation 2011;46(12):1519-25.
2011: Matt Kalaycio; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; A Absi; Steven Andresen; Brian J Bolwell; R Dean; Edward A Copelan
BU- vs TBI-based conditioning for adult patients with ALL.
Bone marrow transplantation 2011;46(11):1413-7.
2011: Brian T Hill; Lisa Rybicki; Stephen Smith; R Dean; Matt Kalaycio; Brad Pohlman; John Sweetenham; Shawnda Tench; Ronald Sobecks; Steven Andresen; Edward A Copelan; Brian J Bolwell
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.
Leukemia & lymphoma 2011;52(6):986-93.
2011: Stephen D Smith; Craig Moskowitz; R Dean; Brad Pohlman; Ronald Sobecks; Edward A Copelan; Steven Andresen; Brian J Bolwell; Jocelyn C Maragulia; Jill M Vanak; John Sweetenham; Alison J Moskowitz
Autologous stem cell transplant for early relapsed/refractory Hodgkin lymphoma: results from two transplant centres.
British journal of haematology 2011;153(3):358-63.
2011: Michael J Burdick; Donald Neumann; Brad Pohlman; Chandana A Reddy; Rahul D Tendulkar; Roger Macklis
External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.
International journal of radiation oncology, biology, physics 2011;79(4):1124-30.
2011: Brenda L Rice; Carol Farver; Brad Pohlman; Brian B Burkey; Joseph G Parambil
Concomitant Castleman's disease and sarcoidosis.
The American journal of the medical sciences 2011;341(3):257-9.
2011: Brian T Hill; Lisa Rybicki; Brian J Bolwell; Stephen Smith; R Dean; Matt Kalaycio; Brad Pohlman; Shawnda Tench; Ronald Sobecks; Steven Andresen; Edward A Copelan; John Sweetenham
The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.
British journal of haematology 2011;152(5):561-9.
2011: S D Smith; Brian J Bolwell; Lisa A Rybicki; T Kang; R Dean; Anjali Advani; Snehal G Thakkar; Ronald Sobecks; Matt Kalaycio; Brad Pohlman; John W Sweetenham
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab.
Bone marrow transplantation 2011;46(2):262-6.
2011: Hien K Duong; Priscilla Figueroa; Eric D Hsi; Matt Kalaycio; AP Koo; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; Steven Andresen; Brian J Bolwell; R Dean; Edward Copelan
Predicting hematopoietic stem cell mobilization failure in patients with multiple myeloma: a simple method using day 1 CD34+ cell yield.
Journal of clinical apheresis 2011;26(3):111-5.
2011: D M Mickelson; L Sproat; R Dean; Ronald Sobecks; L Rybicki; Matt Kalaycio; Brad Pohlman; J Sweetenham; Steven Andresen; Brian J Bolwell; Edward A Copelan
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT.
Bone marrow transplantation 2011;46(1):84-9.
2010: Brian T Hill; Brian J Bolwell; Lisa Rybicki; R Dean; Matt Kalaycio; Brad Pohlman; Shawnda Tench; Ronald Sobecks; Steven Andresen; Edward A Copelan
Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1738-46.
2010: Joshua Weaver; Anuj Kumar Mahindra; Brad Pohlman; Tao Jin; Eric D Hsi
Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Journal of cutaneous pathology 2010;37(5):516-24.
2010: Robert M Dean; Brad Pohlman; John W Sweetenham; Ronald Sobecks; Matt Kalaycio; Stephen D Smith; Edward A Copelan; Steven Andresen; Lisa A Rybicki; Julie Curtis; Brian J Bolwell
Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide.
British journal of haematology 2010;148(2):226-34.
2010: C Stotler; Brian J Bolwell; Ronald Sobecks; R Dean; SE Serafino; Lisa Rybicki; Steven Andresen; Brad Pohlman; Matt Kalaycio; Edward A Copelan
Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
Bone marrow transplantation 2010;45(1):49-52.
2009: Bill G Richendollar; Raymond E Tsao; Paul Elson; Tao Jin; Roxanne Steinle; Brad Pohlman; Eric D Hsi
Predictors of outcome in post-transplant lymphoproliferative disorder: an evaluation of tumor infiltrating lymphocytes in the context of clinical factors.
Leukemia & lymphoma 2009;50(12):2005-12.
2009: A Mahindra; Ronald Sobecks; Lisa Rybicki; Brad Pohlman; R Dean; Steven Andresen; Matt Kalaycio; John W Sweetenham; Brian J Bolwell; E Copelan
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation.
Bone marrow transplantation 2009;44(11):767-8.
2009: Stephen D Smith; Brian J Bolwell; Anjali Advani; Steven Andresen; Josephine L Chan; Robert M Dean; Eric D Hsi; Matt Kalaycio; Brad Pohlman; Lisa A Rybicki; John W Sweetenham
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma.
Leukemia & lymphoma 2009;50(10):1625-31.
2009: Michael C Lee; Monish Aron; Eric D Hsi; Brian R Herts; Brad Pohlman; Inderbir S Gill
Age-related Epstein-Barr virus-associated lymphoproliferative disorder presenting as renal mass.
Urology 2009;74(3):505-8.
2009: Anuj Mahindra; Brian J Bolwell; Ronald Sobecks; Lisa Rybicki; Brad Pohlman; Robert Dean; Steven Andresen; John Sweetenham; Matt Kalaycio; Edward Copelan
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2009;146(3):310-6.
2009: E Copelan; Brad Pohlman; Lisa Rybicki; Matt Kalaycio; Ronald Sobecks; Steven Andresen; R Dean; A Koo; J Chan; John W Sweetenham; Brian J Bolwell
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
Bone marrow transplantation 2009;43(2):101-5.
2008: Ronald Sobecks; R Dean; Lisa A Rybicki; J Chan; Karl S Theil; R Macklis; Steven Andresen; Matt Kalaycio; Brad Pohlman; C Ferraro; K Cherni; John W Sweetenham; E Copelan; Brian J Bolwell
400 cGy TBI with fludarabine for reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;42(11):715-22.
2008: Anuj Mahindra; Brian J Bolwell; Ronald Sobecks; Lisa Rybicki; Brad Pohlman; Robert Dean; Steve Andresen; John Sweetenham; Matt Kalaycio; Edward Copelan
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1239-44.
2008: Matt Kalaycio; Anjali Advani; Brad Pohlman; Mikkael A Sekeres; Barbara Tripp; Lisa Rybicki; Ronald Sobecks
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
American journal of hematology 2008;83(11):831-4.
2008: Ronald Sobecks; Edward J Ball; M Askar; Karl S Theil; LA Rybicki; D Thomas; S Brown; Matt Kalaycio; Steven Andresen; Brad Pohlman; R Dean; John W Sweetenham; R Macklis; L Bernhard; K Cherni; E Copelan; Jaroslaw P Maciejewski; Brian J Bolwell
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;41(8):709-14.
2008: Aimee V Chappelow; Arun D Singh; Victor Perez Quinones; Alan E Lichtin; Brad Pohlman; Roger M Macklis
Bilateral panocular involvement with mantle-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1167.
2007: Todd Kelley; Rose Beck; Ahmed Absi; Tao Jin; Brad Pohlman; Eric Hsi
Biologic predictors in follicular lymphoma: importance of markers of immune response.
Leukemia & lymphoma 2007;48(12):2403-11.
2007: Todd W Kelley; Brad Pohlman; Paul Elson; Eric D Hsi
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression.
American journal of clinical pathology 2007;128(6):958-65.
2007: Tyler Y Kang; LA Rybicki; Brian J Bolwell; Snehal G Thakkar; S Brown; R Dean; Mikkael A Sekeres; Anjali Advani; Ronald Sobecks; Matt Kalaycio; Brad Pohlman; John Sweetenham
Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma.
Bone marrow transplantation 2007;40(10):973-8.
2007: Matt Kalaycio; Lisa Rybicki; Brad Pohlman; R Dean; John Sweetenham; Steven Andresen; Ronald Sobecks; Mikkael A Sekeres; Anjali Advani; S Brown; Brian J Bolwell
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.
Bone marrow transplantation 2007;40(8):753-8.
2007: Brian J Bolwell; Brad Pohlman; Lisa Rybicki; Ronald Sobecks; R Dean; J Curtis; Steven Andresen; AP Koo; V Mineff; Matt Kalaycio; John Sweetenham
Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
Bone marrow transplantation 2007;40(5):437-41.
2007: S D Smith; Brian J Bolwell; LA Rybicki; S Brown; R Dean; Matt Kalaycio; Ronald Sobecks; Steven Andresen; Eric D Hsi; Brad Pohlman; John Sweetenham
Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
Bone marrow transplantation 2007;40(3):239-43.
2007: Ronald Sobecks; Edward J Ball; Jaroslaw P Maciejewski; LA Rybicki; S Brown; Matt Kalaycio; Brad Pohlman; Steven Andresen; Karl S Theil; R Dean; Brian J Bolwell
Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors.
Bone marrow transplantation 2007;39(7):417-24.
2006: Navin Wadehra; Sherif S Farag; Brian J Bolwell; Patrick J Elder; Sam Penza; Matt Kalaycio; Belinda R Avalos; Brad Pohlman; Guido Marcucci; Ronald Sobecks; Thomas Lin; Steven Andrèsen; Edward A Copelan
Long-term outcome of Hodgkin disease patients following high-dose busulfan, etoposide, cyclophosphamide, and autologous stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1343-9.
2006: Matt Kalaycio; Brad Pohlman; Elizabeth Kuczkowski; Lisa Rybicki; Steven Andresen; Ronald Sobecks; Brian J Bolwell
High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant.
Clinical transplantation 2006;20(6):783-7.
2006: S R Fanning; Lisa Rybicki; Matt Kalaycio; Steven Andresen; Elizabeth Kuczkowski; Brad Pohlman; Ronald Sobecks; John Sweetenham; Brian J Bolwell
Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies.
British journal of haematology 2006;135(3):374-81.
2006: Roger M Macklis; Brad Pohlman
Radioimmunotherapy for non-Hodgkin's lymphoma: a review for radiation oncologists.
International journal of radiation oncology, biology, physics 2006;66(3):833-41.
2006: Matt Kalaycio; Lisa Rybicki; Brad Pohlman; Ronald Sobecks; Steven Andresen; Elizabeth Kuczkowski; Brian J Bolwell
Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3604-10.
2006: Eric D Hsi; Stephen J Sup; Carlos Alemany; Elisa Tso; Marek Skacel; Paul Elson; Miguel A Alonso; Brad Pohlman
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
American journal of clinical pathology 2006;125(5):776-82.
2006: Rony M Abou-Jawde; Ronald Sobecks; Brad Pohlman; Lisa Rybicki; Anjali Advani; Mikkael A Sekeres; Matt Kalaycio
The role of post-remission chemotherapy for older patients with acute myelogenous leukemia.
Leukemia & lymphoma 2006;47(4):689-95.
2006: Brad Pohlman; John Sweetenham; Roger M Macklis
Review of clinical radioimmunotherapy.
Expert review of anticancer therapy 2006;6(3):445-61.
2006: William Blum; Brian J Bolwell; Gary Phillips; Sherif S Farag; Thomas S Lin; Belinda R Avalos; Sam Penza; Guido Marcucci; John C Byrd; Matt Kalaycio; Ronald Sobecks; Brad Pohlman; Stacey Brown; Patrick J Elder; Edward A Copelan
High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1):61-7.
2005: R Dean; Paul Masci; Brad Pohlman; Steven Andresen; SE Serafino; Ronald Sobecks; Elizabeth Kuczkowski; J Curtis; Jaroslaw Maciejewski; Lisa Rybicki; Matt Kalaycio; Eric D Hsi; Karl S Theil; Brian J Bolwell
Dendritic cells in autologous hematopoietic stem cell transplantation for diffuse large B-cell lymphoma: graft content and post transplant recovery predict survival.
Bone marrow transplantation 2005;36(12):1049-52.
2005: Abhay S Gokhale; Jyoti Mayadev; Brad Pohlman; Roger M Macklis
Gamma camera scans and pretreatment tumor volumes as predictors of response and progression after Y-90 anti-CD20 radioimmunotherapy.
International journal of radiation oncology, biology, physics 2005;63(1):194-201.
2005: Stephen J Sup; Carlos A Alemañy; Brad Pohlman; Paul Elson; Sareena Malhi; Snehal G Thakkar; Roxanne Steinle; Eric D Hsi
Expression of bcl-2 in classical Hodgkin's lymphoma: an independent predictor of poor outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3773-9.
2005: Sherif S Farag; Brian J Bolwell; Patrick J Elder; Matt Kalaycio; Thomas Lin; Brad Pohlman; Sam Penza; Guido Marcucci; William Blum; Ronald Sobecks; Belinda R Avalos; John C Byrd; Edward A Copelan
High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia.
Bone marrow transplantation 2005;35(7):653-61.
2005: Robin Avery; Matt Kalaycio; Brad Pohlman; Ronald Sobecks; Elizabeth Kuczkowski; Steven Andresen; Sherif B Mossad; J Shamp; J Curtis; J Kosar; K Sands; M Serafin; Brian J Bolwell
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course.
Bone marrow transplantation 2005;35(5):497-9.
2005: Sherif B Mossad; Matt Kalaycio; Ronald Sobecks; Brad Pohlman; Steven Andresen; Robin Avery; Lisa Rybicki; J Jarvis; Brian J Bolwell
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection.
Bone marrow transplantation 2005;35(4):375-81.
2005: Matt Kalaycio; Lisa Rybicki; Brad Pohlman; Ronald Sobecks; E Ball; D Cook; Steven Andresen; Elizabeth Kuczkowski; Brian J Bolwell
CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
Bone marrow transplantation 2005;35(3):247-52.
2004: Robin K Avery; Brian J Bolwell; Belinda Yen-Lieberman; Nell S Lurain; W J Waldman; David L Longworth; Alan J Taege; Sherif B Mossad; D Kohn; J R Long; J Curtis; Matt Kalaycio; Brad Pohlman; J W Williams
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection.
Bone marrow transplantation 2004;34(12):1071-5.
2004: Brian J Bolwell; Ronald Sobecks; Brad Pohlman; Steven Andresen; Lisa Rybicki; Elizabeth Kuczkowski; Matt Kalaycio
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation.
Bone marrow transplantation 2004;34(7):621-5.
2004: W H W Tang; S Thomas; Matt Kalaycio; Ronald Sobecks; Steven Andresen; J Jarvis; Lisa Rybicki; Brad Pohlman; G S Francis; Brian J Bolwell
Clinical outcomes of patients with impaired left ventricular ejection fraction undergoing autologous bone marrow transplantation: can we safely transplant patients with impaired ejection fraction?
Bone marrow transplantation 2004;34(7):603-7.
2004: Frederic Tort; Elias Campo; Brad Pohlman; Eric Hsi
Heterogeneity of genomic breakpoints in MSN-ALK translocations in anaplastic large cell lymphoma.
Human pathology 2004;35(8):1038-41.
2004: Eric D Hsi; Imran Mirza; Gerard Lozanski; John Hill; Brad Pohlman; Matthew T Karafa; Robert Coupland
A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences.
Archives of pathology & laboratory medicine 2004;128(8):863-8.
2004: Brian J Bolwell; Brad Pohlman; Ronald Sobecks; Steven Andresen; S Brown; Lisa Rybicki; V Wentling; Matt Kalaycio
Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant.
Bone marrow transplantation 2004;33(4):419-23.
2003: Tahir Latif; Brad Pohlman; Matt Kalaycio; Ronald Sobecks; Eric D Hsi; Steven Andresen; Brian J Bolwell
Syngeneic graft-versus-host disease: a report of two cases and literature review.
Bone marrow transplantation 2003;32(5):535-9.
2003: X-Y He; Brad Pohlman; Alan E Lichtin; Lisa Rybicki; Matt Kalaycio
Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
Leukemia 2003;17(6):1078-84.
2003: Brian J Bolwell; Ronald Sobecks; Brad Pohlman; Steven Andresen; Karl S Theil; SE Serafino; Lisa Rybicki; Matt Kalaycio
Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone.
Bone marrow transplantation 2003;31(2):95-8.
2002: Brian J Bolwell; Matt Kalaycio; Ronald Sobecks; Steven Andresen; Elizabeth Kuczkowski; L Bernhard; R Lomax; J Kohuth; S Mendiola; Lisa Rybicki; Brad Pohlman
A multivariable analysis of factors influencing mucositis after autologous progenitor cell transplantation.
Bone marrow transplantation 2002;30(9):587-91.
2002: Robin K Avery; Brad Pohlman; Sherif B Mossad; Marlene Goormastic; David L Longworth; Matt Kalaycio; Ronald Sobecks; Steven Andresen; Elizabeth Kuczkowski; L Bernhard; H Ostendorf; K Wise; Brian J Bolwell
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Bone marrow transplantation 2002;30(5):311-4.
2002: Xing-Yue He; Paul Elson; Brad Pohlman; Alan E Lichtin; Mohamad Hussein; Steven Andresen; Matt Kalaycio
Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial.
BMC cancer 2002;2():12.
2002: Brian J Bolwell; Matt Kalaycio; Ronald Sobecks; Steven Andresen; M McBee; L Kuczkowski; Lisa Rybicki; Brad Pohlman
Autologous hematopoietic cell transplantation non-Hodgkin's lymphoma: 100 month follow-up.
Bone marrow transplantation 2002;29(8):673-9.
2001: Sherif B Mossad; Robin K Avery; David L Longworth; Elizabeth Kuczkowski; M McBee; Brad Pohlman; Ronald Sobecks; Matt Kalaycio; Steven Andresen; R M Macklis; Brian J Bolwell
Infectious complications within the first year after nonmyeloablative allogeneic peripheral blood stem cell transplantation.
Bone marrow transplantation 2001;28(5):491-5.
2001: Brian J Bolwell; Steven Andresen; Brad Pohlman; Ronald Sobecks; Marlene Goormastic; Lisa Rybicki; K Bell; Matt Kalaycio
Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer.
Bone marrow transplantation 2001;27(8):843-6.
2001: Matt Kalaycio; Brad Pohlman; Paul Elson; Alan E Lichtin; Mohamad Hussein; B Tripp; Steven Andresen
Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor.
American journal of clinical oncology 2001;24(1):58-63.
2000: Brian J Bolwell; Matt Kalaycio; Steven Andresen; Marlene Goormastic; M McBee; Elizabeth Kuczkowski; K Wise; Ronald Sobecks; Brad Pohlman
Autologous peripheral blood progenitor cell transplantation for transformed diffuse large-cell lymphoma.
Clinical lymphoma 2000;1(3):226-31; discussion 232-3.
2000: Brad Pohlman; Roger M Macklis
Lymphoma and pregnancy.
Seminars in oncology 2000;27(6):657-66.
2000: JA Lyons; J Myles; Brad Pohlman; Roger M Macklis; Joseph Crowe; Richard L Crownover
Treatment of prognosis of primary breast lymphoma: a review of 13 cases.
American journal of clinical oncology 2000;23(4):334-6.
2000: Edward A Copelan; Sam Penza; Brad Pohlman; Belinda R Avalos; Marlene Goormastic; Steven Andresen; Matt Kalaycio; Thomas Bechtel; MD Scholl; Patrick J Elder; SA Ezzone; Lynn C O'Donnell; MB Tighe; G L Risley; Donn C Young; Brian J Bolwell
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.
Bone marrow transplantation 2000;25(12):1243-8.
2000: Steven Neil Wolff; Joseph Fay; D Stevens; Roger H Herzig; Brad Pohlman; Brian J Bolwell; J Lynch; Solveig G Ericson; Cesar O Freytes; F LeMaistre; R Collins; LA Pineiro; John Greer; Richard Stein; Stacey A Goodman; Stephen Dummer
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
Bone marrow transplantation 2000;25(8):853-9.
2000: Robin Avery; Brad Pohlman; Karim A Adal; Brian J Bolwell; M Goldman; Matt Kalaycio; G Hall; Steven Andresen; Sherif B Mossad; S Schmitt; P Mason; David L Longworth
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients.
Bone marrow transplantation 2000;25(1):67-9.
1999: Brian J Bolwell; Brad Pohlman; Matt Kalaycio; K Wise; Marlene Goormastic; Steven Andresen
LDH elevation after autologous stem cell transplantation.
Bone marrow transplantation 1999;24(1):53-5.
1999: JL Shapiro; ML Miller; Brad Pohlman; E Mascha; AJ Fishleder
CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
American journal of clinical pathology 1999;111(4):477-87.
1998: Brian J Bolwell; Marlene Goormastic; Steven Andresen; AP Koo; K Wise; Beth Overmoyer; Brad Pohlman; Matt Kalaycio
Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation.
Bone marrow transplantation 1998;22(6):547-51.
1998: Brian J Bolwell; Brad Pohlman; Steven Andresen; Matt Kalaycio; Marlene Goormastic; K Wise; A Wakeling; R Dannley; Beth Overmoyer
Delayed G-CSF after autologous progenitor cell transplantation: a prospective randomized trial.
Bone marrow transplantation 1998;21(4):369-73.
1998: H Abdel-Razeq; Brad Pohlman; Steven Andresen; Matt Kalaycio; Beth Overmoyer; K Wise; R Dannley; D DeMars; Marlene Goormastic; Brian J Bolwell
A randomized study of multi-day infusion of autologous peripheral blood progenitor cells.
Bone marrow transplantation 1998;21(3):221-3.
1998: Matt Kalaycio; Z Mendez; Brad Pohlman; Beth Overmoyer; Navdeep Boparai; E Jones; Brian J Bolwell
Continuous-infusion granisetron compared to ondansetron for the prevention of nausea and vomiting after high-dose chemotherapy.
Journal of cancer research and clinical oncology 1998;124(5):265-9.
1997: Brian J Bolwell; Matt Kalaycio; Marlene Goormastic; R Dannley; Steven Andresen; Alan E Lichtin; Beth Overmoyer; Brad Pohlman
Progressive disease after ABMT for Hodgkin's disease.
Bone marrow transplantation 1997;20(9):761-5.
1997: Brian J Bolwell; Marlene Goormastic; Steven Andresen; Beth Overmoyer; Brad Pohlman; Matt Kalaycio
Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
Bone marrow transplantation 1997;20(6):459-63.
1997: Brian J Bolwell; Marlene Goormastic; R Dannley; Steven Andresen; Beth Overmoyer; Z Mendez; M Kalaycioglu; D DeMars; K Wise; Brad Pohlman
G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 micrograms/kg/day.
Bone marrow transplantation 1997;19(3):215-9.
1996: Abdelghani Tbakhi; M Edinger; J Myles; Brad Pohlman; Raymond R Tubbs
Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders.
Cytometry 1996;25(2):113-24.
1996: Brad Pohlman
Ifosfamide in the treatment of non-Hodgkin's lymphoma.
Seminars in oncology 1996;23(3 Suppl 6):27-32.
1995: Brian J Bolwell; W Maurer; J Anderson; R Dannley; Marlene Goormastic; J Zgrabik; K Sands; Alan E Lichtin; Steven Andresen; Brad Pohlman
Outpatient bone marrow harvest: the Cleveland Clinic experience.
Bone marrow transplantation 1995;16(5):703-5.